Clinical trial
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
NCT00054210
Study timeline
Study start (actual)2003-01-01Date precision: month
Registry last updated2020-10-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
paclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
CTI BioPharmalead sponsor
Mapped research locations
HoustonTexas, United States1San AntonioTexas, United States1BirminghamAlabama, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1TucsonArizona, United States1EdmontonAlberta, Canada1TorranceCalifornia, United States1TulsaOklahoma, United States1Grand RapidsMichigan, United States1CantonOhio, United States1ColumbiaMissouri, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00054210 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.